Navigation Links
Vyta Corp Acquires 100% Ownership of BIOAGRA, LLC
Date:11/5/2008

DENVER, Nov. 5 /PRNewswire-FirstCall/ -- Vyta Corp (OTC Bulletin Board: VYTC) today announced that it has reached a favorable settlement in its foreclosure litigation against BIOAGRA, LLC. Pursuant to the terms of the amicable agreement, Vyta Corp now controls 100% ownership interest in BIOAGRA, LLC, and Paul H. Metzinger, President and CEO of Vyta Corp, becomes the sole Manager, and only executive officer of BIOAGRA, LLC. Terms of the agreement are included in a Form 8-K filed today with the Securities and Exchange Commission, and can be viewed on its website at (http://www.sec.gov).

BIOAGRA, LLC manufactures, markets and distributes AGRASTIM(R), a proprietary all-natural, biologically active yeast Beta-1,3/1,6-D-glucan feed supplement. AGRASTIM(R) has been listed by The Organic Materials Review Institute (OMRI) as approved for use in organic production.

About Vyta Corp

Vyta Corp, based in Denver, Colorado, is traded on the over-the-counter NASDAQ stock market (OTCBB: VYTC) as well as on the Frankfurt, Hamburg, XETRA and Munich Exchanges (OTC: VYTA).

In addition to its 100% ownership of BIOAGRA, LLC, Vyta Corp owns various patents and intellectual properties related to NCS(R) (NanoPierce Connection System) an advanced electronic connection system. For more information on Vyta Corp, please visit its website at http://www.vytacorp.com .

About BIOAGRA, LLC

BIOAGRA, LLC is based in Hinesville, Georgia, where it produces, markets and sells AGRASTIM(R), a purified, all natural, nontoxic yeast Beta 1,3/1,6-D glucan product with a high bioactivity function that improves the immune systems of animals and humans. AGRASTIM(R) is also used to replace growth promotion antibiotics that are currently used in the feed of the beef and dairy cattle, equine, swine, poultry and aquaculture industries.

This announcement contains forward-looking statements about Vyta Corp that may involve risks and uncertainties. Important factors relating to the Company's operations could cause results to differ materially from those in forward-looking statements and further detailed in filings with the Securities and Exchange Commission (SEC) available at the SEC website ( http://www.sec.gov ). All forward-looking statements are based on information available to Vyta Corp on the date hereof and Vyta Corp assumes no obligation to update such statements.

Contacts:

Vyta Corp

Paul H. Metzinger

President & Chief Executive Officer

370 17th St.

Suite 3640

Denver, CO 80202

303-592-1010

Fax: 303-592-1054

E-mail: paul@vytacorp.com


'/>"/>
SOURCE Vyta Corp
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Affitech Acquires Pharmexas Diabody Technology
2. Millstone Medical Outsourcing Acquires New Facility to Accommodate Growing Business, Provide Additional Clean Room Capacity
3. CPA Acquires Renowned German Patent Research Specialist, SVPG
4. Circassia Acquires North American and Japanese Rights to Dopexamine
5. Advanced Instruments Acquires D & F Control Systems Inc.
6. Milestone Scientific Acquires Additional Patent Rights for Painless Injections and Resolves Related Litigations
7. MediCult Acquires US-Based MidAtlantic Diagnostics to Further Strengthen ART Presence
8. Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
9. Safecor Health Acquires Unit-Dose Pharmaceutical Leader RSC
10. Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice
11. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)...   BioInformant announces the February 2016 release ... Opportunities, Tools, and Technologies – Market Size, Segments, Trends, ... The first and only market ... BioInformant has more than a decade of historical information ... stem cell type. This powerful 175 page global strategic ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... cell treatment clinic in Quito, Ecuador. The new facility will provide advanced protocols ... patients from around the world. , The new GSCG clinic is headed ...
(Date:2/10/2016)... Feb. 10, 2016  The Maryland House of Delegates ... announced that University of Maryland School of Medicine Dean ... University of Maryland Medical System President and CEO ... Medallion," the highest honor given to the public by ... Dean Reece and Mr. Chrencik for their ...
(Date:2/10/2016)... New York, and New York, New York (PRWEB) , ... ... ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it ... and develop new vaccines and immunotherapies for infectious diseases and cancer. ...
Breaking Biology Technology:
(Date:2/1/2016)... , Feb. 1, 2016  Today, the first ... (AHA) announced plans to develop a first of its ... power of IBM Watson. In the first application of ... IBM (NYSE: IBM ), and Welltok will create ... health assessments with cognitive analytics, delivered on Welltok,s health ...
(Date:1/25/2016)... 25, 2016  Glencoe Software, the world-leading supplier of ... industries, will provide the data management solution OMERO Plus ... Photo - ... Phenotypic analysis measures the characteristics and ... comparisons between states such as health and disease, the ...
(Date:1/20/2016)... 20, 2016   MedNet Solutions , an innovative ... of clinical research, is pleased to announce the attainment ... are the result of the company,s laser focus on ... , it,s comprehensive, easy-to-use and highly affordable cloud-based ... Key MedNet growth achievements in 2015 include: ...
Breaking Biology News(10 mins):